Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

12.01 +0.29 (+2.52%)
Delayed Quote Updated: 1:42 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
21 22 Next >
News headline image
3 High-Growth Biotech Stocks Poised for Success in 2023 ↗
If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity 
Via InvestorPlace
News headline image
2 Monster Growth Stocks That Can Double in Value, According to Wall Street ↗
These stocks have some promising growth opportunities, but they also come with a fair amount of risk. 
Via The Motley Fool
News headline image
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today? ↗
While CRSPR stock captured the spotlight for potentially encouraging drug data, the news lifted other gene-editing stocks. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023 ↗
 
Via Benzinga
News headline image
Where Intellia Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Analyst Ratings for Intellia Therapeutics ↗
 
Via Benzinga
News headline image
Why Is Intellia Therapeutics (NTLA) Stock Up 10% Today? ↗
Huge opportunities also meets unignorable risks 
Via InvestorPlace
News headline image
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global ↗
 
Via Benzinga
News headline image
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures ↗
For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine. 
Via InvestorPlace
News headline image
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it. 
Via InvestorPlace
News headline image
Why Intellia Therapeutics Stock Jumped This Week ↗
Intellia Therapeutics landed a historic regulatory nod from the FDA. 
Via The Motley Fool
News headline image
Intellia Therapeutics Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Top CRISPR Stocks ↗
CRISPR is a narrow niche of the biotechnology industry, but it could become the fastest growing and most significant of all the biotech businesses. 
Via Talk Markets
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗
 
Via Benzinga
News headline image
3 Beaten-Down Stocks That Could Soar This Year ↗
These stocks could enjoy big rebounds in 2023. 
Via The Motley Fool
News headline image
Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money ↗
There are no guarantees that any stock will generate huge returns. But the odds look pretty good for these three growth stocks. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 ↗
 
Via Benzinga
News headline image
2 Cathie Wood Stocks That Have Tripled Since the 2020 Market Crash ↗
Are these stocks still good buys today? 
Via The Motley Fool
News headline image
7 Cathie Wood Stocks for Your March Buy List ↗
These top Cathie Wood stocks are just now attempting to pivot higher after a miserable outing for much of 2022. 
Via InvestorPlace
News headline image
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review ↗
Many leaders flashed buy signals as the indexes rebounded from support. 
Via Investor's Business Daily
News headline image
Why Is Intellia Therapeutics Stock Trading Higher Today? ↗
Intellia Therapeutics (NASDAQ: NTLA) shares are trading higher on Thursday after the company announced that the FDA cleared its Investigational New Drug application for NTLA-2002 for the treatment of... 
Via Benzinga
News headline image
Intellia Therapeutics Stock Surges On A First-Ever In CRISPR Gene Editing ↗
The FDA made a bold move in the CRISPR gene-editing realm. 
Via Investor's Business Daily
News headline image
3 More Mid-Cap Biotechs The Street Sees Doubling
According to Wall Street research groups, these three mid-cap biotechs have 2x potential. It’s for the investor to decide if the upside justifies the risk. 
Via MarketBeat
News headline image
Better Buy: Beam Therapeutics or Intellia Therapeutics? ↗
The two clinical-stage gene-editing companies have good long-term prospects. 
Via The Motley Fool
News headline image
3 Deeply Undervalued Stocks That Could Double Your Money ↗
These cutting-edge biotech stocks hold tremendous upside potential. 
Via The Motley Fool
News headline image
Earnings Scheduled For February 23, 2023 ↗
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
News headline image
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street ↗
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
News headline image
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129% ↗
Cathie Wood is bullish about these stocks. And so are Wall Street analysts. 
Via The Motley Fool
News headline image
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.